Clinical Trial Update: Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating cisplatin, docetaxel, radiotherapy, and amifostine for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Amifostine (amifostine)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cancer of Head and Neck, Head Cancer | Phase 1, Phase 2 | Status: COMPLETED